What's Happening

Stay up to date on conferences, social posts, and what’s new with Healthesystems

Events

Let’s connect at one of our upcoming conferences or speaking engagements
June 06 - Jun 09, 2024

PRIMA Annual Conference

Healthesystems is attending PRIMA, which brings together top industry risk management professionals.

Nashville, TN
June 13 - Jun 14, 2024

Iowa Workers' Compensation Symposium

Healthsystems is attending the IA Workers’ Compensation Symposium, which brings together special interest groups concerned with the Iowa Workers’ Compensation Law.

Des Moines, IA
View all Events

MedMonitor

An up-to-date timeline of FDA approvals that could impact workers' comp
View All MedMonitor Information

Rezenopy (naloxone hydrochloride) nasal spray

Approval Date: Apr 2024

Note: New Product

Indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression

hello world!

Selarsdi (Ustekinumab-aekn) injection

Approval Date: Apr 2024

Note: Biosimilar, New Product

A biosimilar of Stelara®, this drug is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis

hello world!

Risvan® (risperidone) for extended-release injectable suspension

Approval Date: Mar 2024

Note: New Product

A long-acting, atypical antipsychotic indicated for the treatment of schizophrenia

hello world!

Winrevair (sotatercept-csrk) injections

Approval Date: Mar 2024

Note: Biologic, New Product

A first-in-class biologic indicated for the treatment of pulmonary arterial hypertension to increase exercise capacity and reduce the risk of clinical worsening events

hello world!

Opsynvi® (macitentan and tadalafil) tablets

Approval Date: Mar 2024

Note: New Product

Indicated for the treatment of pulmonary arterial hypertension, both in patients who are treatment naïve or who are already on an ERA, PDE5 inhibitor or both

hello world!

Tryvio (aprocitentan) tablets

Approval Date: Mar 2024

Note: New Product

Indicated for the treatment of hypertension in combination with other antihypertensive drugs to lower blood pressure

hello world!

Simlandi® (adalimumab-ryvk) injection

Approval Date: Feb 2024

Note: Biosimilar

A biosimilar to Humira, this drug is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and plaque psoriasis

hello world!

Tybost (cobicistat) tablets

Approval Date: Feb 2024

Note: First-Time Generic

Indicated for the treatment of HIV-1 infection

hello world!

Dilaudid (hydromorphone hydrochloride) injection

Approval Date: Feb 2024

Note: First-Time Generic

Indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate

hello world!

Namzaric® (memantine and donepezil hydrochloride) extended release capsules

Approval Date: Dec 2023

Note: First-Time Generic

Indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily

hello world!
1 2 3 12

Social Hub

Check out our latest posts and activity
View All Social Media
    lockenvelopephone-handsetmagnifiermenucross-circle